UASt regulatory sequences drive expression of full-length Ret that carries a M955T amino acid substitution in the kinase domain; this change is orthologous to a human RET variant that has been identified in patients with multiple endocrine neoplasia type 2B. In addition, the coding sequence is tagged at the C-terminal end with Tag:LOV(VfAU1) (a light-activated dimerization switch); this allows the active mutant Ret receptor (a dimer) to be induced in a light-dependent manner.
T21184017C
M955T | Ret-PA; M955T | Ret-PB; M955T | Ret-PC
M955T
Analogous M918T mutation in human RET implicated in multiple endocrine neoplasia and thyroid carcinoma; mutation carried on in vitro construct.